Accès gratuit
Numéro
Med Sci (Paris)
Volume 23, Numéro 11, Novembre 2007
Page(s) 975 - 979
Section M/S revues
DOI https://doi.org/10.1051/medsci/20072311975
Publié en ligne 15 novembre 2007
  1. Theilgaard-Monch K, Raaschou-Jensen K, Palm H, et al. Flow cytometric assessment of lymphocyte subsets, lymphoid progenitors, and hematopoietic stem cells in allogeneic stem cell grafts. Bone Marrow Transplant 2001; 28 : 1073–82.
  2. Peggs KS, Verfuerth S, D’Sa S, et al. Assessing diversity: immune reconstitution and T-cell receptor BV spectratype analysis following stem cell transplantation. Br J Haematol 2003; 120 : 154–65.
  3. Dalle JH, Menezes J, Wagner E, et al. Characterization of cord blood natural killer cells: Implications for transplantation and neonatal infections. Pediatr Res 2005; 57 : 649–55.
  4. Rossi M, Young JW. Human dendritic cells: potent antigen-presenting cells at the crossroads of innate and adaptive immunity. J Immunol 2005; 175 : 1373–81.
  5. Liu YJ. IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol 2005; 23 : 275–306.
  6. Borras FE, Matthews NC, Lowdell MW, Navarrete CV. Identification of both myeloid CD11c+ and lymphoid CD11c- dendritic cell subsets in cord blood. Br J Haematol 2001; 113 : 925–31.
  7. Hunt DW, Huppertz HI, Jiang HJ, Petty RE. Studies of human cord blood dendritic cells: evidence for functional immaturity. Blood 1994; 84 : 4333–43.
  8. Goriely S, Vincart B, Stordeur P, et al. Deficient IL-12(p35) gene expression by dendritic cells derived from neonatal monocytes. J Immunol 2001; 166 : 2141–6.
  9. Krumbiegel D, Rohr J, Schmidtke P, et al. Efficient maturation and cytokine production of neonatal DCs requires combined proinflammatory signals. Clin Dev Immunol 2005; 12 : 99–105.
  10. De Wit D, Olislagers V, Goriely S, et al. Blood plasmacytoid dendritic cell responses to CpG oligodeoxynucleotides are impaired in human newborns. Blood 2004; 103 : 1030–2.
  11. Yan SR, Qing G, Byers DM, et al. Role of MyD88 in diminished tumor necrosis factor alpha production by newborn mononuclear cells in response to lipopolysaccharide. Infect Immun 2004; 72 : 1223–9.
  12. Chang M, Suen Y, Lee SM, et al. Transforming growth factor-beta 1, macrophage inflammatory protein-1 alpha, and interleukin-8 gene expression is lower in stimulated human neonatal compared with adult mononuclear cells. Blood 1994; 84 : 118–24.
  13. Lee SM, Suen Y, Chang L, et al. Decreased interleukin-12 (IL-12) from activated cord versus adult peripheral blood mononuclear cells and upregulation of interferon-gamma, natural killer, and lymphokine-activated killer activity by IL-12 in cord blood mononuclear cells. Blood 1996; 88 : 945–54.
  14. Qian JX, Lee SM, Suen Y, Knoppel E, et al. Decreased interleukin-15 from activated cord versus adult peripheral blood mononuclear cells and the effect of interleukin-15 in upregulating antitumor immune activity and cytokine production in cord blood. Blood 1997; 90 : 3106–17.
  15. De WD, Tonon S, Olislagers V, et al. Impaired responses to toll-like receptor 4 and toll-like receptor 3 ligands in human cord blood. J Autoimmun 2003; 21 : 277–81.
  16. Wilson CB, Westall J, Johnston L, et al. Decreased production of interferon-gamma by human neonatal cells. Intrinsic and regulatory deficiencies. J Clin Invest 1986; 77 : 860–7.
  17. Hassan J, O’Neill S, O’Neill LA, et al. Signalling via CD28 of human naive neonatal T lymphocytes. Clin Exp Immunol 1995; 102 : 192–8.
  18. Nonoyama S, Penix LA, Edwards CP, et al. Diminished expression of CD40 ligand by activated neonatal T cells. J Clin Invest 1995; 95 : 66–75.
  19. Zola H, Fusco M, Macardle PJ, et al. Expression of cytokine receptors by human cord blood lymphocytes: comparison with adult blood lymphocytes. Pediatr Res 1995; 38 : 397–403.
  20. Barbey C, Irion O, Helg C, et al. Characterisation of the cytotoxic alloresponse of cord blood. Bone Marrow Transplant 1998; 22 (suppl 1) : S26–30.
  21. Hermann E, Truyens C, Alonso-Vega C, et al. Human fetuses are able to mount an adultlike CD8 T-cell response. Blood 2002; 100 : 2153–8.
  22. Renda MC, Fecarotta E, Dieli F, et al. Evidence of alloreactive T lymphocytes in fetal liver: implications for fetal hematopoietic stem cell transplantation. Bone Marrow Transplant 2000; 25 : 135–41.
  23. Flake AW, Zanjani ED. In utero hematopoietic stem cell transplantation. A status report. JAMA 1997; 278 : 932–7.
  24. Godfrey WR, Spoden DJ, Ge YG, et al. Cord blood CD4+CD25+-derived T regulatory cell lines express FoxP3 protein and manifest potent suppressor function. Blood 2005; 105 : 750–8.
  25. Cupedo T, Nagasawa M, Weijer K, et al. Development and activation of regulatory T cells in the human fetus. Eur J Immunol 2005; 35 : 383–90.
  26. Ribeiro-do-Couto LM, Boeije LC, Kroon JS, et al. High IL-13 production by human neonatal T cells: neonate immune system regulator ? Eur J Immunol 2001; 31 : 3394–402.
  27. Roth I, Corry DB, Locksley RM, et al. Human placental cytotrophoblasts produce the immunosuppressive cytokine interleukin 10. J Exp Med 1996; 184 : 539–48.
  28. O’Garra A, Howard M. IL-10 production by CD5 B cells. Ann NY Acad Sci 1992; 651 : 182–99.
  29. Moore KW, de Waal MR, Coffman RL, O’Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19 : 683–765.
  30. Payvandi F, Amrute S, Fitzgerald-Bocarsly P. Exogenous and endogenous IL-10 regulate IFN-alpha production by peripheral blood mononuclear cells in response to viral stimulation. J Immunol 1998; 160 : 5861–8.
  31. Gluckman E, Broxmeyer HA, Auerbach AD, et al. Hematopoietic reconstitution in a patient with Fanconi’s anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 1989; 321 : 1174–8.
  32. Dalle JH, Duval M, Moghrabi A, et al. Results of an unrelated transplant search strategy using partially HLA-mismatched cord blood as an immediate alternative to HLA-matched bone marrow. Bone Marrow Transplant 2004; 33 : 605–11.
  33. Gluckman E, Rocha V, Boyer-Chammard A, et al. Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med 1997; 337 : 373–81.
  34. Holler E. Cytokines, viruses, and graft-versus-host disease. Curr Opin Hematol 2002; 9 : 479–84.
  35. Cohen JL, Trenado A, Vasey D, et al. CD4+CD25+ immunoregulatory T Cells: new therapeutics for graft-versus-host disease. J Exp Med 2002; 196 : 401–6.
  36. Medawar PB. Immunological tolerance. Science 1961; 133:303–6.
  37. Harris DT, Schumacher MJ, LoCascio J, et al. Immunoreactivity of umbilical cord blood and post-partum maternal peripheral blood with regard to HLA-haploidentical transplantation. Bone Marrow Transplant 1994; 14 : 63–8.
  38. Rein DT, Breidenbach M, Honscheid B, et al. Preeclamptic women are deficient of interleukin-10 as assessed by cytokine release of trophoblast cells in vitro. Cytokine 2003; 23 : 119–25.

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.